Dermata Therapeutics, Inc. (DRMA) Insider Trading

Name: Dermata Therapeutics, Inc. (DRMA) insider trading: SEC Form 4 filings
Creator: Insiders Notifier
License: https://www.sec.gov/privacy#dissemination

Latest Form 4 (Aug 18, 2026): PROEHL GERALD T (PRESIDENT, CHAIRMAN, CEO): Grant/Award of 170,068 shares.

Get alerted when insiders trade DRMA

Email address

Loading company data...

Beta

Loading company details...

Beta